Visceral leishmaniasis simulating chronic liver disease: Successful treatment with miltefosine

被引：0

作者：

Avasthi, R.

Chaudhary, S. C. ^{[1
]}

Khanna, S.

机构：

[1] Univ Delhi, Univ Coll Med Sci, Dept Med, Delhi 110095, India

来源：

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：85 / 86

页数：2

共 5 条

[1] Aggarwal P, 1990, Indian J Gastroenterol, V9, P135
[2] Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis
Bhattacharya, Sujit Kumar
Sinha, Prabhat Kumar
Sundar, Shyam
Thakur, Chandreshar Prasad
Jha, Tara Kant
Pandey, Krishna
Das, Vidyanand Rabi
Kumar, Naveen
Lal, Chandrasekhar
Verma, Neena
Singh, Vijay Pratap
Ranjan, Alok
Verma, Rakesh Bihari
Anders, Gerlind
Sindermann, Herbert
Ganguly, Nirmal Kumar
[J]. JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (04) : 591 - 598
[3] Prakash A, 2006, J Assoc Physicians India, V54, P893
[4] Salgado Filho Natalino, 2003, Rev. Soc. Bras. Med. Trop., V36, P217, DOI 10.1590/S0037-86822003000200004
[5] Oral miltefosine for Indian visceral leishmaniasis
Sundar, S
Jha, TK
Thakur, CP
Engel, J
Sindermann, H
Fischer, C
Junge, K
Bryceson, A
Berman, J
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (22) : 1739 - 1746